The actual purchase price of Platinib in 2025
Pralsetinib is a targeted drug mainly used to treat non-small cell lung cancer (NSCLC) carrying RET gene rearrangements, as well as some other specific types of tumors. By inhibiting the activity of RET tyrosine kinase, platinib blocks the growth and spread of cancer cells, thereby providing patients with an effective treatment option. Studies have shown that platinib shows good efficacy in treating this type of cancer, especially in patients who have previously received poor results from other treatments.

In the Chinese market, the original drug Platinib has been launched, but unfortunately it has not yet been included in the medical insurance system. This means that patients are responsible for paying the entire cost when purchasing the drug. The common packaging specification of Platinib is 100mg per bottle, with 60 and 120 tablets available. However, the price of platinib is relatively high. One box may cost more than 20,000 yuan, and the price in some areas is even as high as 60,000 yuan. This imposes a significant financial burden on many patients, especially in the context of long-term treatment.
In overseas markets, the price of platinib is also high. The price of a box of 60 tablets of Platinib's original drug fluctuates greatly, usually between 40,000 yuan and more than 100,000 yuan, which is mainly affected by exchange rate changes. However, there is also good news in the market. With the advancement of research and development, the first generic version of Platinib has been launched overseas. The ingredients of this generic drug are similar to those of the original drug on the market, and it has undergone strict quality control to ensure its efficacy and safety. Take the 120-tablet generic drug produced in Laos as an example. Its price is about more than 3,000 yuan, which has a significant advantage over the price of the original drug. This undoubtedly provides a more economical option for patients who wish to receive platinib treatment, and also promotes the availability of platinib at home and abroad.
Reference: https://gavreto.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)